期刊文献+

2个Huntington病家系临床特征及CAG重复性分析 被引量:2

Clinical characteristics of Huntington disease in two pedigrees and analysis of expanded CAG trinucleotide repeat
下载PDF
导出
摘要 目的:探讨Huntington病(Huntington disease,HD)的临床和遗传特征。方法:对收集的2个中国汉族HD家系患者的临床资料进行综合分析,应用聚合酶链式反应及基因扫描方法对其中9例家系成员的IT15基因的三核苷酸重复序列进行分析。结果:在两个家系中确诊了6例患者(男女均有发病),患者IT15基因的基因型均为杂合子,致病CAG重复拷贝数介于4078次。两个家系中子代较父代发病年龄提前,家系2中可见发病年龄与CAG重复拷贝数呈负相关。6例患者中有1例为少年型HD,其临床表现明显不同于成人型,以肌张力障碍为主要表现。结论:HD是一种由CAG重复序列异常扩增所致的神经变性病,存在遗传早现现象;少年型HD的临床表现不同于成人型,CAG重复拷贝数与发病年龄及疾病严重程度有关。 Objective: To understand the clinical and genetic features of Huntington disease(HD).Methods: The clinical data of HD cases from 2 Chinese families were analyzed and trinucleotide repeat in the IT15 gene were investigated in 9 of the two families by polymerase chain reaction and GeneScan.Results: Among the two pedigrees,6 cases were ascertained as HD by genetic test.Genotypes of IT15 were heterozygous in these HD patients.CAG repeat of the patients in the HD chromosome were 40-78.In the two pedigrees,the onset age was earlier in the subsequent generations than that of their fathers.In pedigree 2,the onset age was inversely correlated with CAG repeat number.One out of the 6 cases was juvenile-onset type of Huntington disease,whose clinical symptoms were different from those of the adult-onset cases,especially the hypertonic manifestation.Conclusion: HD is an autosomal dominant neurodegenerative disorder with genetic anticipation caused by enlargement of CAG repeat in IT15 gene.The clinical manifestation is different between the juvenile-onset and the adult-onset.The number of CAG repeat is inversely correlated with the onset age and clinical severity.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2011年第2期163-167,共5页 Journal of Peking University:Health Sciences
关键词 HUNTINGTON病 基因 三核苷酸重复 早现 遗传 Huntington disease; Genes; Trinucleotide repeats; Anticipation,genetic
  • 相关文献

参考文献22

  • 1赵育海.Huntington舞蹈病发病机制及治疗新进展[J].国外医学(神经病学.神经外科学分册),2001,28(3):191-195. 被引量:5
  • 2Gusella JF,WexlerN S,Conneally PM,et al.A polymorphic DNA marker genetically linked to Huntingtonps disease[J].Nature,1983,306(17):234 -237.
  • 3Gusella JF,Huntington' s Disease Collaborative Research Group.A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntingtonps disease chromosomes[J].Cell,1993,72(6):971 -976.
  • 4Rasmussen A,Macias R,Yescas P,et al.Huntington disease in children:genotype-phenotype correlation[J].Neuropediatrics,2000,31(4):190-194.
  • 5The American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group.ACMG/ASHG statement:laboratory guidelines for Huntington disease genetic testing[J].Am J Hum Genet,1998,62(5):1243 -1247.
  • 6Semaka A,Collins JA,Hayden MR.Unstable familial transmissions of Huntington disease alleles with 27-35 CAG repeats (intermediate alleles)[J].Am J Med Genet B Neuropsychiatr Genet,2010,153B(1):314 -320.
  • 7Parisi V,Persi G,Varela V,et al.Huntington disease prevalence in a cohort from argentina:analysis of normal CAG repeats in Huntingtin gene among HD patients and control[J].Neurology,2010,74(9):412 -413.
  • 8Langbehn DR,Hayden MR,Paulsen JS.CAG-repeet length and the age of onset in Huntington disease (HD):a review and validation study of statistical approaches[J].Am J Med Genet B Neuropsychiatr Genet,2010,153(2):397 -408.
  • 9Andresen JM,Gayan J,Djousse L,et al.The relationship between CAG repeat length and age of onset differs for Huntington' s disease patients with juvenile onset or adult onset[J].Ann Hun Genet,2007,71 (3):295-301.
  • 10Swami M,Hendricks AE,Gillis T,et al.Somatic expansion of the Huntington' s disease CAG repeat in the brain is associated with an earlier age of disease onset.Human molecular genetics[J].2009,18(16):3039-3047.

二级参考文献27

  • 1Hodgson JG, Agopyan N, Gutekunst CA, et al. A YAC mouse model for Huntington' s disease with full- length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron, 1999, 23(1): 181- 192.
  • 2DiFiglia M, Sapp E, Chase KO, et al. Aggregation of huntingtin in neuronal intranuclear inclusion and dystrophic neurites in brain. Science, 1997, 277 (5334): 1990-1993.
  • 3Gutekunst CA, Li SH, Yi H, et al. Nuclear and neuropil aggregates in huntington' s disease: relationship to neuropathology. J Neurosci,1999, 19 (7): 2522-2534.
  • 4Ona VO, Li M, Vonsattel JP, et al. Inhibition of caspase- 1 slows disease progression in a mouse model of Huntington' s disease. Nature,1999, 399 (6733): 263-267.
  • 5Heiser V, Scherzinger E, Boeddrich A, et al. Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: Implication for Huntington' s disease therapy. Proc Natl Acad Sci USA, 2000, 97(12): 6739 - 6744.
  • 6Saudon F, FinkbeinerS, Devys D, etal. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranulear inclusions. Cell, 1998, 95 (1): 55 - 56.
  • 7Goldberg YP, Nicholson DW, Rasper DM, et al. Cleavage of huntingtin by apopain, a proapopotic cysteine protease, is modulated by the polyglutamine tract. Nat Genet, 1996, 13 (4): 442-449.
  • 8Portera- Cailliau C, Hedreen JC, Price DL, et al. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci, 1995, 15 (5): 3775-3787.
  • 9Bachoud- Lévi AC, Rémy P, Nguyen JP, et al. Motor and cognitive improvements in patients with Huntington' s disease after neural transplantation. Lancet, 2000, 356 (9246): 1975-1979.
  • 10Freeman TB, Cicchetti F, Hauser RA, et al. Transplanted fetal striatum in Huntington' s disease: Phenotypic development and lack of pathology. Proc Nad Acad Sci USA, 2000, 97 (25): 13877 - 13882.

共引文献9

同被引文献11

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部